Rapid switching from morphine to methadone in cancer patients with poor response to morphine

Journal of Clinical Oncology

Volumn 17, Issue 10, 1999, Pages 3307-3312

  Mercadante, Sebastiano ^a   Casuccio, Alessandra ^a   Calderone, Luciano ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; CISAPRIDE; CORTICOSTEROID; HALOPERIDOL; LACTULOSE; METHADONE; METOCLOPRAMIDE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; ONDANSETRON; PROSTAGLANDIN; RANITIDINE;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CLINICAL ARTICLE; DROWSINESS; DRUG CROSS TOLERANCE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PRIORITY JOURNAL; SENNA; SURVIVAL; XEROSTOMIA;

EID: 0032887667     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1999.17.10.3307     Document Type: Article

References (32)

1. Mercadante S: Predictive factors and opioid responsiveness in cancer pain. Eur J Cancer 34:627-631, 1998
2. Portenoy RK, Foley KM, Inturrisi CE: The nature of opioid responsiveness and its implications for neuropathic pain: New hypotheses derived from studies of opioid infusions. Pain 43:273-286, 1990
3. Crews JC, Sweeney NJ, Denson DD: Clinical efficacy of methadone in patients refractory to other mu-opioid receptor agonist for management of terminal cancer pain. Cancer 72:2266-2272, 1993
4. Morley JS, Watt JWG, Wells JC, et al: Methadone in pain uncontrolled by morphine. Lancet 342:1243, 1993 (letter)
5. de Stoutz ND, Bruera E, Suarez-Almazor M: Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10:378-384, 1995
6. Leng G, Finnegan MJ: Successful use of methadone in nociceptive cancer pain unresponsive to morphine. Palliat Med 8:153-155, 1994
7. MacDonald N, Der L, Allen S, et al: Opioid hyperexcitability: The application of an alternate opioid therapy. Pain 53:353-355, 1993
8. Rimmer T, Trotman I: Methadone restores opioid sensitivity in cancer pain. Palliat Med 10:58, 1996
9. Bruera E, Franco JJ, Maltoni M, et al: Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage 10:287-291, 1995
10. Viganò A, Fan D, Bruera E: Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators. Pain 67:115-119, 1996
11. Mercadante S: Opioid rotation in cancer pain: Rationale and clinical aspects. Cancer (in press)
12. Portenoy RK, Coyle N: Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Symptom Manage 5:307-319, 1990
13. Morley JS, Makin MK: Comments on Ripamonti et al. Pain 73:114-115, 1997
14. Mercadante S, Casuccio A, Agnello A, et al: Morphine versus methadone in the pain treatment in advanced cancer patients followed-up at home. J Clin Oncol 16:3656-3661, 1998
15. Hawley P, Forbes K, Hanks GW: Opioids, confusion and opioid rotation. Palliat Med 12:63-64, 1998
16. Fallon M, O'Neill B: Opioid toxicity should be managed initially by decreasing the opioid dose. Br J Med 317:81, 1998 (letter)
17. Ripamonti C, Groff L, Brunelli C, et al: Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio? J Clin Oncol 16:3216-3221, 1998
18. Bruera E, Pereira J: Neuropsychiatric toxicity of opioids, in Jensen TS, Turner JA, Wiesenfeld-Hallin Z (eds): Proceedings of the 8th World Congress on Pain. Seattle, WA, IASP Press, 1996, pp 717-738
19. Bruera E, Pereira J, Watanabe S, et al: Opioid rotation in patients with cancer pain: A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer 78:852-857, 1996
20. Lawlor P, Turner K, Hanson J, et al: Dose ratio between morphine and methadone in patients with cancer pain: A retrospective study. Cancer 82:1167-1173, 1998
21. Ripamonti C, De Conno F, Groff L, et al: Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: Comparison of two clinical experiences. Ann Oncol 9:79-83, 1998
22. Hunt G, Bruera E: Respiratory depression in a patient receiving oral methadone for cancer pain. J Pain Symptom Manage 10:401-404, 1995
23. Hammack JE, Loprinzi CL: Use of orally administered opioids for cancer-related pain. Mayo Clin Proc 69:384-390, 1994
24. American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section: Practice guidelines for cancer pain management. Anesthesiology 84:1243-1257, 1996
25. Levy MH: Pharmacologic treatment of cancer pain. N Engl J Med 335:1124-1132, 1996
26. Sawe J: High-dose morphine and methadone in cancer patients: Clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet 11:87-106, 1986
27. Mercadante S: Methadone in cancer pain. Eur J Pain 1:77-85, 1997
28. Sawe J, Hansen J, Ginman C, et al: Patient controlled dose regimen of methadone for chronic cancer pain. Br J Med 282:771-773, 1983
29. Mercadante S, Sapio M, Serretta R, et al: Patient-controlled analgesia with oral methadone in cancer pain: preliminary report. Ann Oncol 7:613-618, 1996
30. De Conno F, Groff L, Brunelli C, et al: Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J Clin Oncol 14:1836-1842, 1996
31. Mercadante S, Casuccio A, Agnello A, et al: Methadone responsiveness in advanced cancer patients with pain followed at home. J Pain Symptom Manage (in press)
32. Hagen N, Swanson R: Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: Treatment strategies. J Pain Symptom Manage 14:51-58, 1997